Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$57.25 -0.12 (-0.21%)
2/9/2010 4:00 PM

Alexandria Real Estate Equities, Inc. (ARE)

CAPS Rating:
*

The Company is engaged principally in the ownership, operation, management, selective redevelopment, development and acquisition of properties for the life sciences industry.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ARE

Add Stock to Watchlist

What the Community Thinks

Total Members

73 Outperforms
56 Underperforms
 

All-Stars

22 Outperforms
18 Underperforms
 

Wall Street

8 Outperforms
1 Underperforms
 

Members bullish on ARE are also bullish on:

Members bearish on ARE are also bearish on:

Ticker Tags

Hard Asset (1002), It's a Verb! (39), Distressed (1597), Among Most Trustworthy Companies (80), Small Cap (1645), Defensive (1457), Real Estate Investment Trusts (REITs) (169), Financials (1255)
Suggest a tag

Alexandria Real Estate Equities, Inc. At A Glance

Current Price: $57.25
Last Trade Time: 2/9/2010 4:00 PM
Open: $58.30
Previous Close: $57.37
Daily Range: $56.50 - $58.30
52-Week Range: $30.33 - $68.24
Volume: 604,528
Market Cap: $2.53B
P/E Ratio: 18.45
Compare Our Special Broker Offers!

Stock Trends

ARE VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

Alexandria Real Estate Equities, Inc. (ARE)

Avatar SuperCharge (98.56) Submitted: 7/13/09 2:16 PM

The "leading provider of real estate..., (and) landlord of Choice to the Life Science Industry".

Debt's a little high but improving & ARE's near the 52 week lows. If you're like me & expect the life science's to hold up ok in this downturn, ARE looks like a pretty good bargain here. Could go lower,...More

Replies: 2 | Reply | Permalink

Top Bear Pitch

Recs

1

Alexandria Real Estate Equities, Inc. (ARE)

Avatar Ewok82 (30.43) Submitted: 5/25/09 12:49 PM

Expensive property in a niche market for life science research seems to be a bit speculative in this market, especially given that some of these properties are in cities like SF, where prices continue to fall as taxes continue to rise.

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 22 :   1 2 3 4 5 Next »

Show Pitch Replies

Recs

1

 (ARE)

Avatar SuperCharge (98.56) Submitted: 7/13/09 2:16 PM : Outperform Start Price: $31.48 ARE Score: 61.69

The "leading provider of real estate..., (and) landlord of Choice to the Life Science Industry".

Debt's a little high but improving & ARE's near the 52 week lows. If you're like me & expect the life science's to hold up ok in this downturn, ARE looks like a pretty good bargain here. Could go lower, but the cut dividend is still yielding 4+% and earnings have shown stregth of late.

The 5 year avg. P/E is 36 and ARE's sitting at about 8 right now. Watch the 2Q earnings report closely. I don't expect it to, but if the 2nd Q's near MSN's projected $1.37 there's no reason why this thing shouldn't skyrocket. That $1.37 figure has to be a mistake because their 2009 guidance is suggesting $2.5 per share. Even still, that puts ARE at reasonable FWD P/E of 12.

Report this Post Replies: 2 | Reply | Permalink

Recs

1

 (ARE)

Avatar Ewok82 (30.43) Submitted: 5/25/09 12:49 PM : Underperform Start Price: $31.43 ARE Score: -59.56

Expensive property in a niche market for life science research seems to be a bit speculative in this market, especially given that some of these properties are in cities like SF, where prices continue to fall as taxes continue to rise.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ARE)

Avatar crabbucket1 (54.10) Submitted: 5/07/09 9:29 AM : Outperform Start Price: $34.57 ARE Score: 43.27

Cheap for the long haul @ <36.00....Too good to pass on for a 1yr term....Project to make 20-25% in 10-12 months...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ARE)

Avatar Chemdawg (87.69) Submitted: 4/18/09 2:54 PM : Outperform Start Price: $40.15 ARE Score: 15.95

still making money ......very strong dividend.....heebner pick

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (ARE)

Avatar Macademia (87.26) Submitted: 1/19/09 1:35 PM : Underperform Start Price: $54.85 ARE Score: 25.16

This stock is completely overpriced with P/E 21.37. Terrible long term debt to equity ratio (2.06), tepid return on equity 8.8, and very high payout ratio...This is unsustainable. And, with the federal government in so much debt, I don't expect the national institute of health (NIH) budget to increase anytime soon and NIH money is very important source of income for life sciences industry...

Report this Post Replies: 1 | Reply | Permalink

Results 1 - 5 of 22 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 9 of 9  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRWBaird 87.00 09/01/09 Outperform NS $55.22+3.68%+5.24%-1.56
TrackJMP 71.98 08/04/09 Outperform NS $39.14+46.29%+7.74%+38.54
TrackUBS 87.99 09/17/08 Outperform NS $100.65-43.12%-7.57%-35.55
TrackChrisDavis < 20 06/03/08 Outperform 1Y $95.62-40.12%-20.18%-19.94 Toggle the visibility of 60-Second Pitch and replies
TrackRonBaron 59.71 03/31/08 Outperform NS $86.15-33.54%-15.75%-17.80 Toggle the visibility of 60-Second Pitch and replies
TrackHeebner 34.75 12/31/07 Outperform NS $93.67-38.88%-23.57%-15.31 Toggle the visibility of 60-Second Pitch and replies
TrackCantorFitz 31.61 01/31/07 Outperform NS $95.43-40.01%-20.21%-19.80
TrackRBCCapMkts 86.33 11/07/06 Underperform NS $85.89-33.34%-17.66%+15.68
TrackRyanBeck 66.05 10/26/06 Outperform NS $87.94-34.90%-17.95%-16.95

Results 1 - 9 of 9  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 109ms